Log in

Relevant bibliographies by topics / Nevirapine / Journal articles

To see the other types of publications on this topic, follow the link: Nevirapine.

Journal articles on the topic 'Nevirapine'

Author: Grafiati

Published: 4 June 2021

Last updated: 26 July 2025

Create a spot-on reference in APA, MLA, Chicago, Harvard, and other styles

Select a source type:

Consult the top 50 journal articles for your research on the topic 'Nevirapine.'

Next to every source in the list of references, there is an 'Add to bibliography' button. Press on it, and we will generate automatically the bibliographic reference to the chosen work in the citation style you need: APA, MLA, Harvard, Chicago, Vancouver, etc.

You can also download the full text of the academic publication as pdf and read online its abstract whenever available in the metadata.

Browse journal articles on a wide variety of disciplines and organise your bibliography correctly.

1

Autar, Reshma S., Ferdinand WNM Wit, Jongkol Sankote, et al. "Nevirapine Plasma Concentrations and Concomitant Use of Rifampin in Patients Coinfected with HIV-1 and Tuberculosis." Antiviral Therapy 10, no. 8 (2005): 937–43. http://dx.doi.org/10.1177/135965350501000809.

Full text

Abstract:

Objectives In countries with high numbers of HIV/tuberculosis coinfection nevirapine and rifampin are used extensively. However, limited data are available about whether or not nevirapine and rifampin can be safely coadministered without the plasma concentration of nevirapine falling below therapeutic levels. Methods Blood samples for determination of nevirapine plasma concentrations were collected from patients using nevirapine 200 mg twice daily with or without concomitant rifampin. Bivariate and multivariate linear regression models were used to investigate factors possibly related to nevir

APA, Harvard, Vancouver, ISO, and other styles

2

Drummond, Nicola S., F. Javier Vilar, Dean J. Naisbitt, et al. "Drug-Specific T Cells in An HIV-Positive Patient with Nevirapine-Induced Hepatitis." Antiviral Therapy 11, no. 3 (2005): 393–95. http://dx.doi.org/10.1177/135965350601100301.

Full text

Abstract:

Background Nevirapine is associated with idiosyncratic reactions such as skin rash, hepatitis and hypersensitivity syndrome, which have the hallmarks of being immune mediated. However, there is little laboratory evidence to support an immune pathogenesis. Methods A HIV-positive individual who developed hepatitis within 6 weeks of starting nevirapine, in the absence of any cutaneous manifestations, is described. Other causes of hepatitis were excluded, and the patients liver function normalized on withdrawal of nevirapine. Lymphocytes from the patient, and six individuals with HIV who were on n

APA, Harvard, Vancouver, ISO, and other styles

3

Mustafa, Suzana, Mahiran Mustafa, and Wan Nazirah Wan Yusuf. "Methadone Reduced Nevirapine Pharmacokinetic Parameters in People Living With HIV in Malaysia." Malaysian Journal of Medicine and Health Sciences 19, no. 3 (2023): 247–53. http://dx.doi.org/10.47836/mjmhs.19.3.32.

Full text

Abstract:

Introduction: The HIV epidemic in Malaysia predominantly affects males (90% of total HIV cases) mostly intravenous drugs users. Nevirapine-based of highly active antiretroviral therapy (HAART) once- or twice-daily dosage improve accessibility and effectiveness of antiretroviral treatment for HIV positive intravenous drug users (IDUs) receiving methadone maintenance treatment. Studies reported that concomitant administration of nevirapine with methadone reduced methadone plasma concentration. Since methadone and nevirapine were both known to be the substrate for cytochrome 2B6 (CYP 2B6), concom

APA, Harvard, Vancouver, ISO, and other styles

4

&NA;. "Nevirapine." Reactions Weekly &NA;, no. 1378 (2011): 26–27. http://dx.doi.org/10.2165/00128415-201113780-00094.

Full text

APA, Harvard, Vancouver, ISO, and other styles

5

&NA;. "Nevirapine." Reactions Weekly &NA;, no. 690 (1998): 10. http://dx.doi.org/10.2165/00128415-199806900-00025.

Full text

APA, Harvard, Vancouver, ISO, and other styles

6

&NA;. "Nevirapine." Reactions Weekly &NA;, no. 730 (1998): 8. http://dx.doi.org/10.2165/00128415-199807300-00030.

Full text

APA, Harvard, Vancouver, ISO, and other styles

7

&NA;. "Nevirapine." Reactions Weekly &NA;, no. 757 (1999): 10. http://dx.doi.org/10.2165/00128415-199907570-00032.

Full text

APA, Harvard, Vancouver, ISO, and other styles

8

&NA;. "Nevirapine." Reactions Weekly &NA;, no. 769 (1999): 12. http://dx.doi.org/10.2165/00128415-199907690-00032.

Full text

APA, Harvard, Vancouver, ISO, and other styles

9

&NA;. "Nevirapine." Reactions Weekly &NA;, no. 1168 (2007): 21–22. http://dx.doi.org/10.2165/00128415-200711680-00063.

Full text

APA, Harvard, Vancouver, ISO, and other styles

10

&NA;. "Nevirapine." Reactions Weekly &NA;, no. 1178 (2007): 28–29. http://dx.doi.org/10.2165/00128415-200711780-00083.

Full text

APA, Harvard, Vancouver, ISO, and other styles

11

&NA;. "Nevirapine." Reactions Weekly &NA;, no. 1179 (2007): 26. http://dx.doi.org/10.2165/00128415-200711790-00078.

Full text

APA, Harvard, Vancouver, ISO, and other styles

12

&NA;. "Nevirapine." Reactions Weekly &NA;, no. 1126 (2006): 16. http://dx.doi.org/10.2165/00128415-200611260-00049.

Full text

APA, Harvard, Vancouver, ISO, and other styles

13

&NA;. "Nevirapine." Reactions Weekly &NA;, no. 1132 (2006): 19. http://dx.doi.org/10.2165/00128415-200611320-00061.

Full text

APA, Harvard, Vancouver, ISO, and other styles

14

&NA;. "Nevirapine." Reactions Weekly &NA;, no. 1133 (2007): 18–19. http://dx.doi.org/10.2165/00128415-200711330-00060.

Full text

APA, Harvard, Vancouver, ISO, and other styles

15

&NA;. "Nevirapine." Reactions Weekly &NA;, no. 1374 (2011): 27. http://dx.doi.org/10.2165/00128415-201113740-00096.

Full text

APA, Harvard, Vancouver, ISO, and other styles

16

Mirochnick, Mark, Diana F. Clarke, and Alejandro Dorenbaum. "Nevirapine." Clinical Pharmacokinetics 39, no. 4 (2000): 281–93. http://dx.doi.org/10.2165/00003088-200039040-00004.

Full text

APA, Harvard, Vancouver, ISO, and other styles

17

&NA;. "Nevirapine." Reactions Weekly &NA;, no. 773 (1999): 11–12. http://dx.doi.org/10.2165/00128415-199907730-00030.

Full text

APA, Harvard, Vancouver, ISO, and other styles

18

&NA;. "Nevirapine." Reactions Weekly &NA;, no. 804 (2000): 10–11. http://dx.doi.org/10.2165/00128415-200008040-00027.

Full text

APA, Harvard, Vancouver, ISO, and other styles

19

&NA;. "Nevirapine." Reactions Weekly &NA;, no. 832 (2000): 9–10. http://dx.doi.org/10.2165/00128415-200008320-00023.

Full text

APA, Harvard, Vancouver, ISO, and other styles

20

&NA;. "Nevirapine." Reactions Weekly &NA;, no. 861 (2001): 11. http://dx.doi.org/10.2165/00128415-200108610-00029.

Full text

APA, Harvard, Vancouver, ISO, and other styles

21

&NA;. "Nevirapine." Reactions Weekly &NA;, no. 1401 (2012): 28. http://dx.doi.org/10.2165/00128415-201214010-00105.

Full text

APA, Harvard, Vancouver, ISO, and other styles

22

&NA;. "Nevirapine." Reactions Weekly &NA;, no. 1414 (2012): 39. http://dx.doi.org/10.2165/00128415-201214140-00134.

Full text

APA, Harvard, Vancouver, ISO, and other styles

23

&NA;. "Nevirapine." Reactions Weekly &NA;, no. 1198 (2008): 33. http://dx.doi.org/10.2165/00128415-200811980-00103.

Full text

APA, Harvard, Vancouver, ISO, and other styles

24

&NA;. "Nevirapine." Reactions Weekly &NA;, no. 1199 (2008): 33–34. http://dx.doi.org/10.2165/00128415-200811990-00101.

Full text

APA, Harvard, Vancouver, ISO, and other styles

25

&NA;. "Nevirapine." Reactions Weekly &NA;, no. 1201 (2008): 24. http://dx.doi.org/10.2165/00128415-200812010-00070.

Full text

APA, Harvard, Vancouver, ISO, and other styles

26

&NA;. "Nevirapine." Reactions Weekly &NA;, no. 1224 (2008): 22. http://dx.doi.org/10.2165/00128415-200812240-00066.

Full text

APA, Harvard, Vancouver, ISO, and other styles

27

&NA;. "Nevirapine." Reactions Weekly &NA;, no. 1227 (2008): 21. http://dx.doi.org/10.2165/00128415-200812270-00060.

Full text

APA, Harvard, Vancouver, ISO, and other styles

28

&NA;. "Nevirapine." Reactions Weekly &NA;, no. 1104 (2006): 15. http://dx.doi.org/10.2165/00128415-200611040-00043.

Full text

APA, Harvard, Vancouver, ISO, and other styles

29

&NA;. "Nevirapine." Reactions Weekly &NA;, no. 1112 (2006): 17–18. http://dx.doi.org/10.2165/00128415-200611120-00050.

Full text

APA, Harvard, Vancouver, ISO, and other styles

30

&NA;. "Nevirapine." Reactions Weekly &NA;, no. 866 (2001): 10. http://dx.doi.org/10.2165/00128415-200108660-00028.

Full text

APA, Harvard, Vancouver, ISO, and other styles

31

&NA;. "Nevirapine." Reactions Weekly &NA;, no. 893 (2002): 12. http://dx.doi.org/10.2165/00128415-200208930-00044.

Full text

APA, Harvard, Vancouver, ISO, and other styles

32

&NA;. "Nevirapine." Reactions Weekly &NA;, no. 894 (2002): 9–10. http://dx.doi.org/10.2165/00128415-200208940-00033.

Full text

APA, Harvard, Vancouver, ISO, and other styles

33

&NA;. "Nevirapine." Reactions Weekly &NA;, no. 898 (2002): 9–10. http://dx.doi.org/10.2165/00128415-200208980-00030.

Full text

APA, Harvard, Vancouver, ISO, and other styles

34

&NA;. "Nevirapine." Reactions Weekly &NA;, no. 907 (2002): 12–13. http://dx.doi.org/10.2165/00128415-200209070-00038.

Full text

APA, Harvard, Vancouver, ISO, and other styles

35

&NA;. "Nevirapine." Reactions Weekly &NA;, no. 928 (2002): 9–10. http://dx.doi.org/10.2165/00128415-200209280-00031.

Full text

APA, Harvard, Vancouver, ISO, and other styles

36

&NA;. "Nevirapine." Reactions Weekly &NA;, no. 1314 (2010): 31. http://dx.doi.org/10.2165/00128415-201013140-00097.

Full text

APA, Harvard, Vancouver, ISO, and other styles

37

&NA;. "Nevirapine." Reactions Weekly &NA;, no. 1316 (2010): 33–34. http://dx.doi.org/10.2165/00128415-201013160-00108.

Full text

APA, Harvard, Vancouver, ISO, and other styles

38

&NA;. "Nevirapine." Reactions Weekly &NA;, no. 1321 (2010): 25. http://dx.doi.org/10.2165/00128415-201013210-00080.

Full text

APA, Harvard, Vancouver, ISO, and other styles

39

&NA;. "Nevirapine." Reactions Weekly &NA;, no. 1324 (2010): 28. http://dx.doi.org/10.2165/00128415-201013240-00085.

Full text

APA, Harvard, Vancouver, ISO, and other styles

40

&NA;. "Nevirapine." Reactions Weekly &NA;, no. 984 (2004): 12. http://dx.doi.org/10.2165/00128415-200409840-00037.

Full text

APA, Harvard, Vancouver, ISO, and other styles

41

&NA;. "Nevirapine." Reactions Weekly &NA;, no. 1054 (2005): 12. http://dx.doi.org/10.2165/00128415-200510540-00040.

Full text

APA, Harvard, Vancouver, ISO, and other styles

42

&NA;. "Nevirapine." Reactions Weekly &NA;, no. 1056 (2005): 12. http://dx.doi.org/10.2165/00128415-200510560-00033.

Full text

APA, Harvard, Vancouver, ISO, and other styles

43

&NA;. "Nevirapine." Reactions Weekly &NA;, no. 1333 (2011): 29. http://dx.doi.org/10.2165/00128415-201113330-00092.

Full text

APA, Harvard, Vancouver, ISO, and other styles

44

&NA;. "Nevirapine." Reactions Weekly &NA;, no. 1340 (2011): 31. http://dx.doi.org/10.2165/00128415-201113400-00110.

Full text

APA, Harvard, Vancouver, ISO, and other styles

45

&NA;. "Nevirapine." Reactions Weekly &NA;, no. 1342 (2011): 25. http://dx.doi.org/10.2165/00128415-201113420-00091.

Full text

APA, Harvard, Vancouver, ISO, and other styles

46

&NA;. "Nevirapine." Reactions Weekly &NA;, no. 1343 (2011): 25. http://dx.doi.org/10.2165/00128415-201113430-00094.

Full text

APA, Harvard, Vancouver, ISO, and other styles

47

Bardsley-Elliot, Anne, and Caroline M. Perry. "Nevirapine." Paediatric Drugs 2, no. 5 (2000): 373–407. http://dx.doi.org/10.2165/00128072-200002050-00005.

Full text

APA, Harvard, Vancouver, ISO, and other styles

48

Patel, Sanjay S., and Paul Benfield. "Nevirapine." Clinical Immunotherapeutics 6, no. 4 (1996): 307–17. http://dx.doi.org/10.1007/bf03259093.

Full text

APA, Harvard, Vancouver, ISO, and other styles

49

Jong, Menno D. "Nevirapine." Clinical Immunotherapeutics 6, no. 4 (1996): 318. http://dx.doi.org/10.1007/bf03259094.

Full text

APA, Harvard, Vancouver, ISO, and other styles

50

Havlir, Diane. "Nevirapine." Clinical Immunotherapeutics 6, no. 4 (1996): 318. http://dx.doi.org/10.1007/bf03259095.

Full text

APA, Harvard, Vancouver, ISO, and other styles

We offer discounts on all premium plans for authors whose works are included in thematic literature selections. Contact us to get a unique promo code!